Intentar ORO - Gratis
Specialised Skill Development for GCCs in India
Bio Spectrum
|BioSpectrum India May 2025
India is a key hub for Life Sciences and Healthcare (LSHC) Global Capability Centers (GCCs).

With over 280,000 professionals, 40 per cent are focused on clinical research and using AI for healthcare advancements. The AI talent pool in India is projected to grow to 633,000 by 2025, emphasising the need for specialised skills and continuous learning to maintain its reputation as a top destination for LSHC GCCs.
India has solidified its position as a pivotal hub for Global Capability Centers (GCCs), especially in the Life Sciences and Healthcare (LSHC) sectors. These centres are instrumental in driving advancements in research and development, digital transformation, regulatory compliance, pharmacovigilance, clinical trial analytics, and supply chain management for global pharmaceutical and healthcare enterprises. To sustain this momentum, developing a workforce with specialised skills is essential. Currently, LSHC GCCs in India employ over 280,000 professionals. Of this talent pool, 43 per cent are engaged in core healthcare and R&D, 16 per cent specialise in IT, and 41 per cent focus on business process management.
This article delves into the initiatives undertaken for skill development, the contributions of industry leaders, emerging competencies, and the role of GCC consortiums in fortifying the talent pipeline for LSHC GCCs in India.
Escalating Demand for Specialised Skills in LSHC GCCs
As India cements its status as a preferred destination for LSHC GCCs, there is an escalating demand for professionals proficient in Regulatory Affairs & Compliance for navigating guidelines from authorities such as the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and Central Drugs Standard Control Organisation (CDSCO) of India for drug approvals; Clinical Research & Data Management for executing clinical trials, analysing real-world evidence, and managing extensive healthcare datasets.
Esta historia es de la edición BioSpectrum India May 2025 de Bio Spectrum.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Bio Spectrum

Bio Spectrum
Navigating the Complexities of Pharma Packaging Sustainability
Pharma companies in India are increasingly adopting sustainable methods in packaging to ensure that medicines remain safe and the environment is protected. Various initiatives by the government, focusing on reducing carbon footprints, are revolutionising the pharma packaging industry.
8 mins
September 2025

Bio Spectrum
Are BioStartUps in a Funding/Innovation Rut?
At the BioStartUps Founders & Investors Forum 2025, held on August 1, 2025 at the CIDCO Exhibition Centre in Vashi, Navi Mumbai, biotech industry stalwarts deliberated on the country's innovation and startup ecosystem.
10 mins
September 2025

Bio Spectrum
How Do Recent Deaths Impact Gene Therapy Development?
Cell and gene therapy (CGT) is among the most closely watched areas in pharma and biotech.
4 mins
September 2025

Bio Spectrum
HealthQuad appoints Namit Chugh as Director
Quadria Group, Asia's leading healthcare-focused private equity platform, has announced the appointment of Namit Chugh as Director at HealthQuad, India's leading healthcare-focused growth venture capital platform.
1 min
September 2025

Bio Spectrum
Why Is Endoscopy Crucial for Gl Cancer Diagnosis?
The increased demand for gastrointestinal (GI) diagnostics in India, driven by rising disease rates and awareness of early intervention, is not evenly distributed. While major urban hospitals have expanded their endoscopic capabilities, many semi-urban and rural areas face limited access. Addressing this disparity is crucial for extending the benefits of early disease detection across the country.
4 mins
September 2025
Bio Spectrum
New England Biolabs launches NEBNext low-bias small RNA library prep kit
US-based New England Biolabs (NEB) has announced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimise biased representation of small RNA species in sequencing data.
1 min
September 2025

Bio Spectrum
Qiagen expands NGS portfolio with launch of QIAseq XHYB long read panels
Qiagen has announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enrichment solutions designed to unlock long-read sequencing of genomically complex regions.
1 min
September 2025

Bio Spectrum
"Awareness and consistent training are needed with the growing demand for effective skin treatments in India"
India’s dermatology and aesthetic market is reportedly among the fastest-growing globally, projected to grow at a CAGR of 10.11 per cent from 2025 to 2032.
4 mins
September 2025
Bio Spectrum
Dr. Moopen's Legacy Scholarship & Fellowships to aid 25 students from across India
In a path breaking initiative to make medical education accessible to meritorious students and students from economically challenged backgrounds, Padma Shri Dr Azad Moopen, Founder & Chairman of Aster DM Healthcare and a globally recognised philanthropist, has announced an annual scholarship programme Dr. Moopen's Legacy Scholarship & Fellowships Programme aimed at supporting meritorious students seeking admissions in Dr. Moopen's Medical College, Dr Moopen's Nursing College and Dr Moopen's College of Pharmacy in Wayanad, Kerala.
1 min
September 2025

Bio Spectrum
Iberia Pharma set to open manufacturing unit in India with investment of Rs 70 Cr
Gurugram-based Iberia Pharmaceuticals has announced its new hi-tech manufacturing and research facility spread across 60,000 sq. ft. in Jhajjar, Haryana.
1 min
September 2025
Listen
Translate
Change font size